Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Blast Pharma Ltd (NASDAQ:ORPN)

5.92
Delayed Data
As of Aug 28
 +0.3101 / +5.53%
Today’s Change
4.50
Today|||52-Week Range
10.00
-7.35%
Year-to-Date
No recent news for Bio Blast Pharma Ltd.

Today’s Trading

Previous close5.61
Today’s open5.66
Day’s range5.14 - 6.10
Volume26,370
Average volume (3 months)37,575
Market cap$84.2M
Dividend yield--
Data as of 3:57pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-307.14%
Earnings growth (this year)-97.37%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.75

Competitors

 Today’s
change
Today’s
% change
PTIEPain Therapeutics In...+0.11+6.29%
HSGXHistogenics Corp+0.08+1.31%
TENXTenax Therapeutics I...0.000.00%
PIPPharmAthene Inc-0.03-2.05%
Data as of 4:02pm ET, 08/28/2015

Financials

Next reporting dateNovember 20, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$7.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Colin J. Foster
Chief Financial Officer &
Director
Ehud-Moshe Gilboa
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers